New FDA Approvals

Leqembi, Aveir Pacemaker, Cyclophosphamide Liquid, IPX203


Listen Later

Get our free download! Implementing AMA Style – 8 Things to Get Right Here are the highlights of this week's episode:

·      The FDA granted traditional approval to Leqembi, an Alzheimer's treatment manufactured by Eisai and Biogen. The approval, based on phase 3 data demonstrating reduced cognitive decline in early Alzheimer's patients, makes Leqembi the first approved drug in its class, offering new treatment possibilities for the 6.5 million Alzheimer's patients in the US.

·      Abbott's Aveir™ DR Dual Chamber Leadless Pacemaker is the first dual chamber leadless pacemaker system for individuals with abnormal or slow heart rhythms. Utilizing the body's natural conductive properties, the device offers more efficient battery usage compared to other communication technologies and reduces the risk of complications associated with traditional pacemakers due to its minimally invasive implantation procedure.

·      The FDA approved a liquid formulation of the cancer drug cyclophosphamide. The new formulation, manufactured by Nevakar, is available in two doses and offers advantages over current powdered forms, including increased stability and reduced risk of dosing errors.

·      Amneal Pharmaceuticals received a Complete Response Letter from the FDA regarding IPX203 for Parkinson's disease. While this extended-release formation of carbidopa/levodopa shows promise with more effective therapeutic benefits than current formulations, the FDA requested additional safety information on a component of the drug, carbidopa. Amneal will continue working with the FDA to address its concerns.

Please check back every Monday morning for last week's approvals so that you can stay up to date. 

Visit our podcast page here.

This podcast is brought to you by Nascent Medical. If you're a project manager at a CME or medical communications agency and need on-call medical writing assistance please visit Nascent Medical. We are a team of MD- and PhD-level medical writers and can create slide decks, white papers, ad board summaries, manuscripts, needs assessments, and much more. We also do medical editing using AMA style and factchecking. Visit nascentmc.com

Intro and outro music

Garden Of Love by Pk jazz Collective

 

...more
View all episodesView all episodes
Download on the App Store

New FDA ApprovalsBy Emma Hitt Nichols, PhD

  • 5
  • 5
  • 5
  • 5
  • 5

5

4 ratings


More shows like New FDA Approvals

View all
NEI Podcast by Neuroscience Education Institute

NEI Podcast

129 Listeners

NEJM This Week by NEJM Group

NEJM This Week

325 Listeners

JAMA Clinical Reviews by JAMA Network

JAMA Clinical Reviews

493 Listeners

STEM-Talk by Dawn Kernagis and Ken Ford

STEM-Talk

652 Listeners

The Curbsiders Internal Medicine Podcast by The Curbsiders Internal Medicine Podcast

The Curbsiders Internal Medicine Podcast

3,332 Listeners

JAMA Medical News by JAMA Network

JAMA Medical News

90 Listeners

The Long Run with Luke Timmerman by Timmerman Report

The Long Run with Luke Timmerman

122 Listeners

AHLA's Speaking of Health Law by American Health Law Association

AHLA's Speaking of Health Law

28 Listeners

Real Life Pharmacology - Pharmacology Education for Health Care Professionals by Eric Christianson, PharmD; Pharmacology Expert and Clinical Pharmacist

Real Life Pharmacology - Pharmacology Education for Health Care Professionals

716 Listeners

The Readout Loud by STAT

The Readout Loud

318 Listeners

The Carlat Psychiatry Podcast by Pocket Psychiatry: A Carlat Podcast

The Carlat Psychiatry Podcast

559 Listeners

Business Of Biotech by Ben Comer

Business Of Biotech

88 Listeners

CEimpact Podcast by CEimpact

CEimpact Podcast

17 Listeners

Truth, Lies & Alzheimer's by Lisa Skinner

Truth, Lies & Alzheimer's

15 Listeners

Conversations in Drug Development by Boyds

Conversations in Drug Development

3 Listeners